GlobeNewswire latest releases

News releases provided by GlobeNewswire GlobeNewswire Inc.
Retrieved on
Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Injection) KALM™-1 Phase 3 Trial Results in the New England Journal of Medicine Mon 11 Nov, 12:00pm
Google News Initiative Partners with Lee Enterprises and TownNews on Dynamic Paywall Mon 11 Nov, 11:45am
Mereo BioPharma’s Setrusumab Demonstrates Dose-Dependent Bone Building and Trend in Fracture Reduction in Phase 2b ASTEROID Study in Adults with Osteogenesis Imperfecta Mon 11 Nov, 11:30am
Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram Mon 11 Nov, 12:00pm
LGI Homes Opens First Community in Greenville-Spartanburg Market Mon 11 Nov, 12:00pm
EVO Payments Names Tom Panther as Chief Financial Officer Mon 11 Nov, 12:00pm
FitLife Brands Announces Third Quarter 2019 Results Mon 11 Nov, 12:00pm
Sharonview Federal Credit Union Partners with UNCC Basketball Mon 11 Nov, 12:00pm
Intertape Polymer Group Reports 2019 Third Quarter Results Mon 11 Nov, 12:00pm
Cerecor Announces Clinical Updates on CERC-301 and CERC-802 Mon 11 Nov, 11:30am
USI Insurance Services Acquires Alfred J. Davis Company Mon 11 Nov, 11:30am
Axogen, Inc. to Participate at Jefferies London Healthcare Conference Mon 11 Nov, 12:00pm
Teleflex to Showcase its Interventional Portfolio Highlighting the MANTA® Vascular Closure Device and the Langston® Dual Lumen Catheters at the PCR London Valves 2019 Mon 11 Nov, 11:45am
Pyxis Tankers Announces Date for the Release of the Third Quarter 2019 Results and Related Conference Call & Webcast Mon 11 Nov, 11:30am
Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications Mon 11 Nov, 11:00am
Brazil Minerals, Inc. Recovers Initial Diamonds From New Area Mon 11 Nov, 11:00am
Ziyen Energy Names David Greenberg Chairman of New ZYEN Digital Energy Trading Platform Mon 11 Nov, 11:00am
Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications Mon 11 Nov, 11:00am
Tile Shop Holdings Provides Update Regarding Delisting and Deregistration Mon 11 Nov, 11:00am
Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update Mon 11 Nov, 11:00am
TGI Fridays and Allegro Merger Corp. Announce Updated Details for Conference Call Today Mon 11 Nov, 11:00am
Barron’s Announces Patti Brennan as a Hall of Fame Advisor Mon 11 Nov, 11:00am
Apergy to Participate in the Bank of America Global Energy Conference Mon 11 Nov, 11:00am
Air Force Veteran is Restoring Hope to Local “U.S.A” Heroes Mon 11 Nov, 11:00am
STMicroelectronics Announces Status of Common Share Repurchase Program Mon 11 Nov, 10:30am
Yiren Digital to Report Third Quarter 2019 Financial Results on November 14, 2019 Mon 11 Nov, 10:00am
Amarin to Present at the Jefferies 2019 London Healthcare Conference Mon 11 Nov, 10:00am
STEYR showcases future farming technology with its STEYR Konzept - a hybrid powered concept tractor Mon 11 Nov, 10:00am
ITRI Wins Two CES 2020 Innovation Awards Mon 11 Nov, 8:44am
ASLAN Pharmaceuticals Announces Topline Results From TreeTopp Global Pivotal Study of Varlitinib in Biliary Tract Cancer Mon 11 Nov, 8:21am
Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors Mon 11 Nov, 7:15am
Cancer Advances, Inc. announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases” in the American Journal of Physiology—Gastrointestinal and Liver Physiology Mon 11 Nov, 8:00am
Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso Mon 11 Nov, 8:00am
Verona Pharma to Participate in Two Upcoming Institutional Investor Conferences in New York Mon 11 Nov, 7:00am
Aurcana Update on Underground Development and Resource Expansion Plans Progress Mon 11 Nov, 7:00am
Cancer Advances, Inc. announces new publication: “Gastrin Vaccine Improves Response to Immune Checkpoint Antibody in Murine Pancreatic Cancer by Altering the Tumor Microenvironment”, in the journal Cancer Immunology, Immunotherapy Mon 11 Nov, 7:00am
OSE Immunotherapeutics Presented Positive Correlation Between Neoepitope Response and Increased Survival for NSCLC Patients Treated with Tedopi® Mon 11 Nov, 7:00am
Bavarian Nordic Completes Enrollment of Phase 3 Lot-Consistency Trial of Freeze-dried Smallpox Vaccine Mon 11 Nov, 6:30am
Unaudited 3rd Quarter Results and Management Discussion and Analysis Mon 11 Nov, 7:00am
Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting Mon 11 Nov, 6:00am
PSAV® ACQUIRES eclipse Mon 11 Nov, 5:00am
Nidec to Issue Green Bonds in Japan Mon 11 Nov, 2:00am
ROSEN, A LEADING GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. – BGNE Mon 11 Nov, 12:00am
GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy Mon 11 Nov, 12:01am
GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy Mon 11 Nov, 12:01am
Robin Hood Holds 7th Annual Investors Conference, Presented By JP Morgan Sun 10 Nov, 9:00pm
ROSEN, A LEADING GLOBAL LAW FIRM, Files First Securities Class Action Lawsuit Against Under Armour, Inc. – UA, UAA Sun 10 Nov, 9:00pm
Keystone resumes crude oil deliveries Sun 10 Nov, 8:00pm
ROSEN, A LEADING GLOBAL LAW FIRM, Reminds Ruhnn Holding Limited Investors of Important Deadline in Securities Class Action First Filed by the Firm – RUHN Sun 10 Nov, 7:45pm
ROSEN, A LEADING GLOBAL LAW FIRM, Reminds Sonim Technologies, Inc. Investors of Important December 6th Deadline in Securities Class Action – SONM Sun 10 Nov, 6:15pm